reference/36903647

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/36903647

Outgoing Links

Predicate	Object
contentType	Journal Article
issn	1043-6618
pageRange	107126-
publicationName	Pharmacological Research
startingPage	107126
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c053cec072f1fe69fb6fbfcc5c928aa6 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_de83723cc6c688b76fe2817c6229dbc8 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b97a01d4f16a2b06e47742ff81232f1e http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_487baf6554eb36bb22c6138d90a7c50f
bibliographicCitation	Lv Q, Zhang Y, Gao W, Wang J, Hu Y, Yang H, Xie Y, Lv Y, Zhang H, Wu D, Hu L, Wang J. CSF1R inhibition reprograms tumor-associated macrophages to potentiate anti-PD-1 therapy efficacy against colorectal cancer. Pharmacol Res. 2024 Apr;202():107126. doi: 10.1016/j.phrs.2024.107126. PMID: 38432446.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bb448157fe18afbc8009b8d446a1fded http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3372da09feb41971f7c707a4114dd8b0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c495d2d185dcdb9df1f4ed8a24866c34 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_83ebea79c8ffd1dd7f3b69cc021cc00d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2a2129ebc8b787c28ad81aadf409fae3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_df0be712a79d5f1db81bb2d70c6fcf2e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7e57f8a058e5417af0d096c7fdce1905 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_16a4f58e457d64039a2cea7fac401325 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_725342d71a1435fb728deb4670f4ff83 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_433cd28a4791b36d9938f4fb6eb312e6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3e35eae82e3aa2fd360dadd52d679296 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8b110896ddfc955f044f16ad578cb6af
date	202404
identifier	https://pubmed.ncbi.nlm.nih.gov/38432446 https://doi.org/10.1016/j.phrs.2024.107126
isPartOf	https://portal.issn.org/resource/ISSN/1043-6618 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/6565
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	CSF1R inhibition reprograms tumor-associated macrophages to potentiate anti-PD-1 therapy efficacy against colorectal cancer
discusses	http://id.nlm.nih.gov/mesh/M0543042 http://id.nlm.nih.gov/mesh/M0556121
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000084582 http://id.nlm.nih.gov/mesh/D015179Q000235
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D019869 http://id.nlm.nih.gov/mesh/D059016 http://id.nlm.nih.gov/mesh/D061026 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D009364

Showing number of triples: 1 to 40 of 40.